Skip to main content
ViGenCell Inc. logo

ViGenCell Inc. — Investor Relations & Filings

Ticker · 308080 ISIN · KR7308080001 KO Professional, scientific and technical activities
Open in API
Filings indexed 134 across all filing types
Latest filing 2022-06-15 Director's Dealing
Country KR South Korea
Listing KO 308080

About ViGenCell Inc.

https://www.vigencell.com/en/

ViGenCell Inc. is a biotechnology company specializing in the development of immune cell therapies. The company focuses on creating treatments for cancer and other incurable diseases by enhancing a patient's own immunity. Its core technologies include the ViTier platform, which utilizes antigen-specific killer T cells to target and remove cancer cells, and the ViRanger platform, a T-cell gene therapy technology. These proprietary platforms form the basis of its pipeline of novel immune cell therapeutics designed to prolong life and improve patient outcomes.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (DART). This type of filing is specifically used to report insider transactions or changes in share ownership by company directors and executives. Based on the provided definitions, this corresponds to 'Director's Dealing'.
2022-06-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership changes of an executive (Kim Byung Su) at Vigencell Co., Ltd. This type of filing is a standard regulatory requirement for insider trading or changes in holdings by company directors/executives, which corresponds to the 'Director's Dealing' category.
2022-06-15 Korean
권리락(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement regarding a 'rights off' (권리락) event due to a bonus issue (무상증자) for the company ViroCure (바이젠셀). This relates to a change in capital structure and share issuance, which falls under the category of share issues or capital changes.
2022-06-07 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short regulatory notice regarding the suspension of stock trading for '바이젠셀 주식회사' due to a bonus issue (무상증자). It cites specific KOSDAQ market regulations and provides the duration of the suspension. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like share issuance or financial reporting, it falls under the general regulatory filing category.
2022-05-25 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean Financial Services Commission/Korea Exchange regarding a 'Decision on Bonus Issue' (무상증자결정). This involves the issuance of new shares to existing shareholders without additional payment, which falls under capital changes. According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the appropriate category for announcements regarding new share issues or capital changes.
2022-05-25 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change Classification · 100% confidence The document is a short regulatory announcement regarding the setting of a record date for a corporate action (bonus issue/capitalization of reserves). It does not contain full financial statements or proxy materials, but rather serves as a formal notice of a corporate event. Given it is a specific regulatory disclosure regarding share-related actions that does not fit into the other specific categories like dividend or share buyback, it falls under the general regulatory filing category.
2022-05-25 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.